We are pleased to announce that the research results of FOREST Technologies, one of our technology platform for the large-scale biochemical analysis of protein-RNA interactions, has been published in Nature Communications.
Title: RNA structure-wide discovery of functional interactions with multiplexed RNA motif library.
Authors: Kaoru R. Komatsu*, Toshiki Taya, Sora Matsumoto, Emi Miyashita, Shunnichi Kashida and Hirohide Saito
*First Author, **Corresponding Author
- Click here for more information(Nature Communications)
- Click here for more information(Center for iPS Cell Research and Application, Kyoto University )
- Click here for more information(Kyoto university press)
About xFOREST Therapeutics
xFOREST Therapeutics Co., Ltd. is a Kyoto-based biotechnology company engaged in the research and development of RNA-targeted small-molecule medicines. Building on its proprietary RNA structure analysis technology, xFOREST discovers selective small molecules for RNA targets that protein-first discovery cannot reach, and advances them into drug programs with partners.